ENT Devices Market Size, Share & Trends Analysis Report By Product (Hearing Aids, Hearing Implants, Diagnostic ENT Devices, Surgical ENT Devices, Nasal Splints), By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global ENT devices market size was valued at USD 21.9 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.69% from 2022 to 2030. Increasing penetration of minimally invasive ENT procedures, increasing prevalence of ENT-related disorders, and rising geriatric population are among the key trends stimulating market growth. Technological advancements also play an important role in the growth of the market.

Demand for advanced ENT devices and systems, such as robot-assisted endoscopes, in developing economies is low due to high cost as their use is concentrated in developed economies, such as the U.S. However, increasing healthcare spending by other governments and a rise in per capita income are anticipated to significantly improve market penetration. Sales are expected to increase at a rapid pace in developing economies due to the high incidence of ENT diseases, such as hearing loss and sinusitis, and an increase in efforts to provide better access to healthcare facilities in these regions.

Hearing loss/impairment has become one of the most common conditions in patients, especially in industrialized countries. According to the WHO, there are over 460 million people worldwide, i.e., around 5% of the world’s population, living with disabling hearing loss, which is expected to increase to over 900 million or 1 in every 10 people by 2050. Two of the main reasons for this are growing life expectancy and increasing noise pollution, which means more cases of age-related hearing loss. Infections such as measles, middle ear infection, or meningitis are also common causes of hearing loss in low-income countries. Moreover, chronic inflammation, noise exposure, vascular disorders, physiological aging of the ear, and genetic susceptibility may cause hearing impairment.

Rising technological advancements such as the adoption of AI and ML and innovations in auditory products are propelling industry growth. For instance, in October 2021, Audibel, a health-technology company, launched Arc-AI, an AI hearing aid. It is programmed to automatically adjust hearing volume and is available in various styles, such as behind-the-ear and completely in-canal styles. In January 2019, Lively launched an online audiology platform that provides hearing aids, tests, and 24/7 online support for all clients. All users of the platform can communicate with an audiologist via video conference and receive hearing aid without the need to visit an office or retail store.

COVID-19 ENT devices market impact: 5.5% increase from 2020 to 2021

Pandemic Impact	Post COVID Outlook
In the worst-hit months of 2020, the mass closure of ENT clinics and termination of elective surgical procedures in hospitals drove down the sales of ENT products.	The resumption of surgical procedures and business operations of companies within the given guidelines is expected to boost growth in the coming years.
The restriction on movement enforced in most markets harmed the entire industry. For instance, audiology stores, the primary consumer channel of hearing care services and products, are either operating with significantly reduced hours or have been shut down.	Market conditions varied greatly across regions, with ENT-related surgery volumes recovering quickly in the U.S., China, Germany, and Australia and more slowly in Spain, the U.K., and Italy. As volumes of ENT-related surgeries grow, demand for ENT products is also expected to rise.

ENT products for minimally invasive procedures are dominated by companies such as Karl Storz, which offers HD video rhino-laryngoscope that can be used for visualization of the nose, pharynx, and larynx in HD image quality. Ambu, Inc. also offers single-use rhino-laryngoscope, which provides ENT specialists an alternative to reusable scopes. In March 2019, the company received CE Mark for Ambu aScope 4 RhinoLaryngo Slim.

Product Insights

The surgical ENT devices segment dominated the market with a revenue share of over 30.0% in 2021. Growing preference for minimally invasive surgeries and the increasing prevalence of ENT disorders are propelling the segment growth. Surgical ENT devices include radiofrequency handpieces, otological drill burs, hand instruments, sinus dilation devices, and nasal packing devices.

New product launches and mergers and acquisitions are key factors driving the segment. For instance, in July 2017, PENTAX Medical-a HOYA Group division and Shanghai Aohua Photoelectricity Endoscope Co., Ltd. announced a joint venture to create products in the field of flexible medical endoscopy.

The hearing implants segment is likely to grow at the fastest rate during the forecast period. This can be attributed to the increasing adoption of hearing implants, rising awareness about cochlear implants as non-invasive procedures, and the launch of new products by key companies. For instance, in August 2021, Cochlear Ltd. launched the Nucleus Kanso-2 sound processor in Singapore. It can be used in off-the-ear cochlear implants and is the smallest sound processor globally. It provides direct streaming from android or iOS devices and is linked to the Nucleus Smart App.

Regional Insights

North America dominated the market for ENT devices and accounted for a share of over 35.0% in 2021. This can be attributed to the high prevalence of ENT-related disorders in the region, increased demand for hearing care products, the presence of large hospital chains, highly equipped ambulatory facilities, and a significant target population. In addition, the local presence of key market players, supportive government regulations for portable medical devices, and high adoption of advanced technology are also key factors driving the market.

在欧洲,市场占second-largest revenue share in 2021. The region has high product penetration for hearing aids due to well-established healthcare infrastructure and high patient awareness levels. Asia Pacific is anticipated to grow at the fastest rate during the forecast period due to increasing awareness about early diagnosis of diseases, growing healthcare expenditure, and rising investment by market players. In May 2018, Olympus Corporation, a Japan-based company, introduced ENF-VT3, a rhino-laryngo videoscope, to integrate 4-direction angulation capability in Europe.

Singapore, Thailand, Australia, and South Korea are some of the emerging countries in the Asia Pacific region. Technological advancements, such as wireless, real-time monitoring, increase in healthcare spending, and support from regulatory bodies are anticipated to promote market growth in the Asia Pacific.

关键企业和市场份额的见解乐鱼APP二维码

The market is highly fragmented with the presence of various domestic and international players. Acquisitions, partnerships, and the launch of new products are key strategies adopted by market players. In March 2020, WS Audiology announced the launch of WIDEX MOMENT-the first generation of hearing aids that sound natural. This is accomplished through Widex's patented ZeroDelay Technology. In September 2019, Cochlear Limited and GN Hearing collaborated with Google and announced support for direct streaming from Android phones to hearing devices, using Bluetooth Low Energy (BLE). Some of the prominent players in the global ENT devices market include:

• Demant A/S

• Sonova

• GN Store Nord A/S

• Ambu A/S

• Pentax Medical

• Karl Storz

• Olympus Corporation

• Richard Wolf GmbH

• Cochlear Ltd.

• Starkey Laboratories, Inc.

• Rion Co., Ltd.

• Stryker

• Smith & Nephew

ENT Devices MarketReport Scope

Report Attribute	Details
The market size value in 2022	USD 23.0 billion
The revenue forecast in 2030	USD 35.9 billion
Growth Rate	CAGR of 5.69% from 2022 to 2030
The base year for estimation	2021
Historical data	2017 - 2020
Forecast period	2022 - 2030
Quantitative units	Revenue in USD million/billion and CAGR from 2022 to 2030
Report coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered	Product, region
Country scope	U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Brazil; Mexico; South Africa
Key companies profiled	Demant A/S; Sonova; GN Store Nord A/S; Ambu A/S; Pentax Medical; Karl Storz; Olympus Corporation; Richard Wolf GmbH; Cochlear Ltd.; Starkey Laboratories, Inc.; Rion Co., Ltd.; Stryker; Smith & Nephew
Customization scope	Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
革命制度党cing and purchase options	利用定制购买选项来满足您的穰ct research needs.Explore purchase options

GlobalENT Devices MarketSegmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global ENT devices market report based on product and region:

• Product Outlook (Revenue, USD Million, 2017 - 2030)

  • Diagnostic ENT Devices

    • Rigid Endoscopes

      • Sinuscopes

      • Otoscopes

      • Laryngoscopes

    • Flexible Endoscopes

      • Bronchoscopes

      • Laryngoscopes

      • Nasopharyngoscopes

    • Robot Assisted Endoscope

    • Hearing Screening Device

  • Surgical ENT Devices

    • Radiofrequency handpieces

    • Otological Drill Burrs

    • ENT Hand Instruments

    • Sinus Dilation Devices

    • Nasal Packing Devices

  • Hearing Aids

  • Hearing Implants

  • Nasal Splints

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • China

    • Japan

    • India

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa (MEA)

    • South Africa